It appears to be a preferable target due to its overexpression in 80% of TNBC
Notice This product is a dietary supplement, not a medicinal product

Project Team: Dr Shane Gordon, NICHE Ulster University (PI) Dr Catherine Hughes, NICHE Ulster University Professor Helene McNulty, NICHE Ulster University Dr Michelle Clements, NICHE Ulster University Dr Fiona Leahy Lithander, University of Auckland Dr Aakash Prasad, University of Auckland Richelle Flanagan, NutritionWise Ireland Willie Wixted, ABC Nutritionals Professor KIERAN TUOHY, University of Leeds Dr Filippos Papadopoulos, Health Economist Key Report findings: Probiotic interventions were linked to improved gastrointestinal health, including an average of one additional bowel movement per week Participants also reported modest improvements in quality of life Economic modelling suggests probiotic support could deliver ~9,000 additional good-health days annually for every 1,000 patients Estimated cost-effectiveness was around 2,400 per QALY, significantly below NHS thresholds The report also highlighted major unmet needs, including persistent constipation, food affordability challenges, and limited access to dietetic support

Xiao Y, Bowen CH, Liu D, Zhang FZ
of Female Employees: 2121 (estimated)